{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:10:21Z","timestamp":1791835821941,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:00:00Z","timestamp":1500422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jmii.2017.07.006","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T04:01:38Z","timestamp":1500955298000},"page":"1-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan"],"prefix":"10.1016","volume":"51","author":[{"given":"Hsiang-Chi","family":"Kung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Yen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bor-Sheng","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Ching","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2017.07.006_bib1","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/jac\/dkl107","article-title":"Treatment outcomes in patients receiving conventional amphotericin B therapy: a prospective multicentre study in Taiwan","volume":"57","author":"Chen","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2017.07.006_bib2","first-page":"19","article-title":"Nosocomial candidemia in a university hospital in Taiwan","volume":"95","author":"Hung","year":"1996","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2017.07.006_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jmii.2012.08.025","article-title":"Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010","volume":"47","author":"Chen","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2017.07.006_bib4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jmii.2013.08.017","article-title":"Changing epidemiology of candidemia in a medical center in middle Taiwan","volume":"48","author":"Hii","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2017.07.006_bib5","doi-asserted-by":"crossref","first-page":"e61921","DOI":"10.1371\/journal.pone.0061921","article-title":"Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997\u20132010","volume":"8","author":"Tseng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2017.07.006_bib6","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s10096-011-1445-1","article-title":"Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000\u20132009","volume":"31","author":"Hsiue","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib7","doi-asserted-by":"crossref","first-page":"165rv113","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jmii.2017.07.006_bib8","first-page":"656","article-title":"Risk factors for ICU mortality in critically ill patients","volume":"100","author":"Chen","year":"2001","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2017.07.006_bib9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/319366","article-title":"Infectious Diseases Society of A. Guide to development of practice guidelines","volume":"32","author":"Kish","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib10","first-page":"523","article-title":"Guidelines for the use of antifungal agents in patients with invasive fungal infections in Taiwan","volume":"39","author":"Infectious Diseases Society of T","year":"2006","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2017.07.006_bib11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1684-1182(10)60041-2","article-title":"Guidelines for the use of antifungal agents in patients with invasive fungal infections in Taiwan\u2013revised 2009","volume":"43","author":"Infectious Diseases Society of T","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2017.07.006_bib12","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib14","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib15","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00277-013-1867-1","article-title":"Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)","volume":"93","author":"Mousset","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jmii.2017.07.006_bib17","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3324\/haematol.2012.065110","article-title":"Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3)","volume":"98","author":"Skiada","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jmii.2017.07.006_bib18","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/bmt.2010.175","article-title":"European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3\u20132009 update","volume":"46","author":"Maertens","year":"2011","journal-title":"Bone Marrow Transpl"},{"issue":"Suppl 3","key":"10.1016\/j.jmii.2017.07.006_bib19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 7","key":"10.1016\/j.jmii.2017.07.006_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12037","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases","volume":"18","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmii.2017.07.006_bib21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jmii.2017.07.006_bib22","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jmii.2017.07.006_bib23","author":"US GRADE Network"},{"key":"10.1016\/j.jmii.2017.07.006_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jmii.2017.07.006_bib25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1684-1182(10)60065-5","article-title":"Changing epidemiology of nosocomial bloodstream infections in 11 teaching hospitals in Taiwan between 1993 and 2006","volume":"43","author":"Liu","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2017.07.006_bib26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jhin.2010.12.007","article-title":"Changes in the incidence of candidaemia during 2000\u20132008 in a tertiary medical centre in northern Taiwan","volume":"78","author":"Chen","year":"2011","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jmii.2017.07.006_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jhin.2010.05.001","article-title":"Secular trends of healthcare-associated infections at a teaching hospital in Taiwan, 1981\u20132007","volume":"76","author":"Chuang","year":"2010","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jmii.2017.07.006_bib28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2307\/30141234","article-title":"Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993","volume":"18","author":"Chen","year":"1997","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jmii.2017.07.006_bib29","series-title":"TNIS Annual Report of Nosocomial Surveillance System","year":"2013"},{"key":"10.1016\/j.jmii.2017.07.006_bib30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jhin.2004.06.003","article-title":"Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres","volume":"59","author":"Sheng","year":"2005","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jmii.2017.07.006_bib31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1345\/aph.1H516","article-title":"Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients","volume":"41","author":"Davis","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jmii.2017.07.006_bib32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0929-6646(09)60091-7","article-title":"Invasive candidiasis: an overview from Taiwan","volume":"108","author":"Ruan","year":"2009","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2017.07.006_bib33","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.cmi.2015.06.010","article-title":"Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study","volume":"21","author":"Tan","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmii.2017.07.006_bib34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(03)00801-6","article-title":"Epidemiology of Candida species infections in critically ill non-immunosuppressed patients","volume":"3","author":"Eggimann","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib35","first-page":"174","article-title":"Invasive fungal infection in children with persistent febrile neutropenia","volume":"104","author":"Lai","year":"2005","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2017.07.006_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/jac\/dkg275","article-title":"Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years","volume":"52","author":"Chen","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2017.07.006_bib37","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1128\/AAC.01035-13","article-title":"Antifungal susceptibilities of Candida isolates causing bloodstream infections at a medical center in Taiwan, 2009\u20132010","volume":"58","author":"Huang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2017.07.006_bib38","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1128\/AAC.00323-08","article-title":"In\u00a0vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates","volume":"52","author":"Ruan","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2017.07.006_bib39","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.kjms.2011.11.011","article-title":"Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents","volume":"28","author":"Chen","year":"2012","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.jmii.2017.07.006_bib40","first-page":"791","article-title":"Molecular epidemiology of Candida colonizing critically ill patients in intensive care units","volume":"100","author":"Chen","year":"2001","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2017.07.006_bib41","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood-2014-04-516211","article-title":"How we treat invasive fungal diseases in patients with acute leukemia: the importance of an individualized approach","volume":"124","author":"Nucci","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jmii.2017.07.006_bib42","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1128\/jcm.32.4.975-980.1994","article-title":"Investigation of the sequence of colonization and candidemia in nonneutropenic patients","volume":"32","author":"Voss","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2017.07.006_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2334-13-10","article-title":"A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study","volume":"13","author":"Yang","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00277-002-0588-7","article-title":"Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: incidence, treatment, and prognosis","volume":"82","author":"Chen","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jmii.2017.07.006_bib45","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jhin.2004.07.020","article-title":"Genotyping analysis of colonizing candidal isolates from very-low-birthweight infants in a neonatal intensive care unit","volume":"58","author":"Huang","year":"2004","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jmii.2017.07.006_bib46","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1469-0691.2006.01435.x","article-title":"Investigation of the possible association between nosocomial candiduria and candidaemia","volume":"12","author":"Binelli","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jmii.2017.07.006_bib47","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3324\/haematol.11882","article-title":"A prospective analysis of the genotypic diversity and dynamics of the Candida albicans colonizing flora in neutropenic patients with de novo acute leukemia","volume":"93","author":"Dalle","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jmii.2017.07.006_bib48","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.diagmicrobio.2013.03.015","article-title":"Molecular concordance of concurrent Candida albicans candidemia and candiduria","volume":"76","author":"Huang","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl 6","key":"10.1016\/j.jmii.2017.07.006_bib49","doi-asserted-by":"crossref","first-page":"S457","DOI":"10.1093\/cid\/cir112","article-title":"Candida urinary tract infections\u2013treatment","volume":"52","author":"Fisher","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/myc.12024","article-title":"Candiduria in haematologic malignancy patients without a urinary catheter: nothing more than a frailty marker?","volume":"56","author":"Georgiadou","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.jmii.2017.07.006_bib51","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00000658-199412000-00008","article-title":"Candida colonization and subsequent infections in critically ill surgical patients","volume":"220","author":"Pittet","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.jmii.2017.07.006_bib52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/1471-2334-14-327","article-title":"Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls","volume":"14","author":"Barton","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib53","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1086\/513196","article-title":"Outcomes attributable to neonatal candidiasis","volume":"44","author":"Zaoutis","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib54","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/qjmed\/95.8.511","article-title":"Cryptococcaemia: clinical features and prognostic factors","volume":"95","author":"Jean","year":"2002","journal-title":"QJM"},{"key":"10.1016\/j.jmii.2017.07.006_bib55","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1110404","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Day","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2017.07.006_bib56","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1086\/598936","article-title":"Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: evidence-based evolving trends","volume":"48","author":"Sun","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib57","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/qjmed\/93.4.245","article-title":"Cryptococcal meningitis in non-HIV-infected patients","volume":"93","author":"Shih","year":"2000","journal-title":"QJM"},{"key":"10.1016\/j.jmii.2017.07.006_bib58","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/cid\/ciu596","article-title":"The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis","volume":"59","author":"Rolfes","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib59","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","article-title":"Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis","volume":"370","author":"Boulware","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2017.07.006_bib60","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2017.07.006_bib61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","article-title":"Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes","volume":"19","author":"Taccone","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.jmii.2017.07.006_bib62","doi-asserted-by":"crossref","first-page":"e0128410","DOI":"10.1371\/journal.pone.0128410","article-title":"High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: a prospective observational study in Taiwan","volume":"10","author":"Tang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2017.07.006_bib63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1378\/chest.120.1.177","article-title":"Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors","volume":"120","author":"Chen","year":"2001","journal-title":"Chest"},{"issue":"250","key":"10.1016\/j.jmii.2017.07.006_bib64","first-page":"2009","article-title":"Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib65","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/myc.12354","article-title":"Azole-resistant Aspergillus fumigatus isolates carrying TR(3)(4)\/L98H mutations in Taiwan","volume":"58","author":"Wu","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.jmii.2017.07.006_bib66","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1086\/504490","article-title":"Invasive fungal pathogens: current epidemiological trends","volume":"43","author":"Pfaller","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib67","first-page":"CD007394","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","author":"Leeflang","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jmii.2017.07.006_bib68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: a randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jmii.2017.07.006_bib69","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/524669","article-title":"Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes","volume":"46","author":"Pascual","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib70","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1128\/AAC.02344-12","article-title":"Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms","volume":"57","author":"Ramage","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2017.07.006_bib71","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/bmt.2009.261","article-title":"Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated","volume":"44","author":"Yokoe","year":"2009","journal-title":"Bone Marrow Transpl"},{"issue":"Suppl 1","key":"10.1016\/j.jmii.2017.07.006_bib72","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2017.07.006_bib73","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13693780500130341","article-title":"Diagnostic challenge of zygomycosis in compromised hosts","volume":"44","author":"Wang","year":"2006","journal-title":"Med Mycol"},{"key":"10.1016\/j.jmii.2017.07.006_bib74","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/JCM.06133-11","article-title":"Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales","volume":"50","author":"Vitale","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2017.07.006_bib75","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1128\/AAC.01488-07","article-title":"Comparison of lipid amphotericin B preparations in treating murine zygomycosis","volume":"52","author":"Ibrahim","year":"2008","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118217301469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118217301469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:22:40Z","timestamp":1761657760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118217301469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1684118217301469"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2017.07.006","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2016 guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2017.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}